Related by context. Frequent words. (Click for all words.) 73 Meets Primary Endpoint 73 Initiates Phase II 72 MKC# 72 6R BH4 72 Initiate Phase 71 forodesine 71 gets USFDA nod 71 Dapagliflozin 71 Pivotal Phase III 70 Inhalation Aerosol 70 Pivotal Phase 70 Panzem R 70 Vytorin combines 70 teriflunomide 69 R sorafenib tablets 69 Sapacitabine 69 Completes Enrollment 69 Presents Positive 69 Receives Orphan Drug Designation 69 Dasatinib 69 Phase III Clinical Trial 69 Belimumab 69 administered subcutaneously 69 Milnacipran 68 Entereg R 68 Laquinimod 68 Single Dose 68 Lubiprostone 68 Study Evaluating 68 Initiates Phase 68 Eltrombopag 68 TELINTRA 68 rufinamide 68 Commences Phase 68 Recombinant Human 68 CDP# 67 post herpetic neuralgia PHN 67 phase IIb clinical 67 REGN# 67 receiving VELCADE 67 Veramyst 67 PRT# 67 Phase 2b clinical trials 67 Mipomersen 67 Sitagliptin 67 alvimopan 67 Avanafil 67 Clevudine 67 Golimumab 67 phase Ib 67 PSN# [002] 67 Plicera 67 Rivaroxaban 67 elotuzumab 67 NVA# 67 SAR# [004] 67 Topiramate 67 Phase III Trial 67 RISPERDAL ® CONSTA ® 66 Ambrisentan 66 JAK inhibitor 66 primary hypercholesterolemia 66 Amrubicin 66 DDP# 66 eltrombopag 66 Coadministration 66 LIALDA 66 Interferon alpha 66 Acetate Rectal Suppositories 66 Drug Candidate 66 Phenoptin 66 Aliskiren 66 refractory chronic lymphocytic 66 Vandetanib 66 inflammatory autoimmune diseases 66 TYGACIL 66 Ticagrelor 66 diabetic neuropathic pain 66 Traficet EN 66 mesylate 66 Phase IIIb 66 double blinded placebo 66 Copegus R 66 PRISTIQ 66 Zomig 66 polymerase inhibitor 66 PEG PAL 66 liposomal formulation 66 INCB# [001] 66 II Clinical Trial 66 motesanib 66 efalizumab 66 Clinical Trial Results 66 Dabigatran 66 Cethromycin 66 KNS # 66 Pegasys ® 66 Daclizumab 66 Tekamlo 66 ARCOXIA 65 Gemzar ®